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1. Introduction 
Localized lack of bone volume in the jaws may be due to congenital, post-traumatic, 
postsurgical defects or different disease processes. Increasing the bone volume has long 
been an attractive field of basic and clinical research. The introduction of implant therapy, 
and the proven relationship between long-term prognosis of dental implants and adequate 
bone volume at the implant site (Lekholm et al. 1986), dramatically increased the interest of 
both clinicians and scientists in this field, making augmentation procedures an important 
part of contemporary implant therapy. Basically, four methods have been described to 
augment bone volume: a. osteoinduction, using appropriate growth factors (Reddi 1981; Urist 
1965); b. osteoconduction, using grafting materials that serve as scaffolds for new bone growth 
(Buch et al. 1986; Reddi et al. 1987); c. distraction osteogenesis, by which a surgically induced 
bone fracture enables slow controlled pulling apart of the separated bone fragments 
(Ilizarov 1989a,b); d. guided bone regeneration, which allows selective bone tissue growth into 
a space maintained by tissue barriers (Dahlin et al. 1988, 1991a; Kostopoulos & Karring 1994; 
Nyman & Lang 1994). Among the different methods, guided bone regeneration (GBR) is the 
most popular and best documented for the treatment of localized bone defects in the jaws, 
probably due to its relative simplicity of use while allowing the placement of endosseous 
implants in areas of the jaw with bony defects and/or insufficient bone volume. Highly 
predictable success rates can be achieved using GBR; in fact, it has been shown that success 
rates of implants placed at GBR treated sites and sites without bone augmentation are 
comparable (Hammerle et al. 2002).  
Guided Tissue Regeneration (GTR) has been introduced into clinical dental practice over 30 
years ago, soon after Melcher (1970,1976), followed by Karring et al. 1980 and Nyman et al. 
1980, presented its basic principles to the professional community. The mechanisms of GBR 
generally followed the same principles i.e. that under certain conditions, cells that originate 
from tissues adjacent to an exclusively provided space are able to form their parent tissue. In 
order to allow exclusive repopulation of cells from desired tissues into that space, preference 
must be given by preventing access of cells from neighboring undesired tissues using tissue 
barriers, commonly referred to as membranes (Figs. 1,2).  
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a. b. c. d. 
Fig. 1. Guided tissue regeneration scheme describing the use of a resorbable barrier 
membrane. a. vertical periodontal lesion in the mandible b. resorbable membrane is 
stabilized over the debrided lesion and covered by the mucosal flap c. after 3- 5 months the 
membrane starts to resorb; new bone, new periodontal ligament and new cementum are 
visible d. reestablishment of most of the periodontal attachment apparatus is completed.  
 
 
a. b. c. d. 
Fig. 2. Guided bone regeneration scheme describing the use of a resorbable barrier 
membrane. a. bony defect is diagnosed b. the defect is debrided, bone cortex is perforated, 
membrane supporting scaffold material and a membrane are placed. c. the membrane is 
stabilized and shaped to dictate the desired bone contours d. a few months later bone 
regeneration is observed restoring the desired shape of the jaw. 
2. Tissue barriers  
A wide range of tissue barrier materials has been used in experimental and clinical studies 
in GTR/GBR procedures, including polytetrafluoroethylene (PTFE), expanded PTFE (e-
PTFE), polyglactin 910, polylactic acid, polyglycolic acid, polyorthoester, polyurethane, 
polyhydroxybutyrate, calcium sulfate, freeze-dried fascia lata,freeze-dried dura mater 
allografts, native and/or synthetic collagen, micro titanium mesh, and titanium foils. 
Among the requirements set for GTR/GBR devices are safety and effectiveness. Based on 
the strict criteria applied to cosmetic/plastic medicine, where no life threatening conditions 
are involved, documentation of the effectiveness of the procedures and materials should be 
available while at the same time adverse effects emerging from the implanted devices 
should be kept to a minimum. In 1994, Hardwick et al. formulated a list of criteria for tissue 
barriers used for GTR; these may also be applied for barriers used for GBR. Briefly, the main 
essential qualities expected are: a. biocompatibility, b. cell occlusiveness, c. integration by 
the host tissues, d. clinical manageability and ease to apply, e. space making ability. Since 
bioabsorbable and biodegradable barriers are degraded in vivo and are absorbed by the 
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body, another additional two requirements need to be fulfilled for these, i.e. that tissue 
reactions resulting from the resorption of the barriers and it's by-products should be 
minimal and reversible and that the regenerative process should not be negatively affected 
(Gottlow 1993). There are a number of factors which are critical for the success or failure of 
GTR/GBR; these include membrane stability, duration of barrier function, ample blood fill 
of the area for regeneration, enhanced access of bone and bone marrow-derived cells to that 
space, and prevention of soft tissue dehiscences over the membrane.  
Tissue barriers may be classified according to several criteria. For the purpose of this 
chapter, however, tissue barriers are divided into two main groups: non-resorbable and 
resorbable. Briefly, non-resorbable barriers are made of thin sheets of materials, mainly 
polymers. They are stable, non-degradable and biocompatible. The earliest commercial and 
most popular non-resorbable membranes were expanded polytetrafluoroethylene (ePTFE) 
membranes; these became a standard for bone regeneration shortly after GBR has been 
recognized as accepted dental therapy. Expanded PTFE is a polymer with high stability in 
biologic systems. It resists breakdown by host tissues and by microbes and does not elicit 
immunologic reactions (Fig. 3). The main limitation of ePTFE and other non  
 
 





Fig. 3. Successful GBR procedure aimed for implant site development using ePTFE membrane. 
a. radiographic view showing secondary caries and root resorbtion indicate extraction of the 
upper right central incisor b. clinical view and examination support the radiographic findings 
c. extraction of the tooth reveals significant bone loss at the esthetic zone d. guided bone 
regeneration using e-PTFE membrane stabilized by two buccal and one palatal titanium 
screws, and by demineralized freezed dried bone allograft supporting the sub-membraneous 
space. e. six months following the procedure the membrane is removed presenting adequate 
Bone volume and proper contours for an implant supported fixed restoration. 
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resorbable membranes is the need for an additional surgery for membrane retrieval. Non-
resorbable membranes have to be removed during a second surgical intervention imposing 
significant additional morbidity on the patient and additional risk for tissue damage.  
A frequent complication associated with non-resorbable membranes is soft tissue dehiscense 
and membrane exposure; these may be followed by infection. Animal experiments 
(Gotfredsen et al. 1993; Kohal et al. 1999a) and clinical studies (Gher et al. 1994; Simion et 
al.1994; Hämmerle et al. 1998) have shown that premature membrane exposure and wound 
dehiscence impair the amount of bone regeneration. Figure 4 presents the exposure and 
removal of an infected e-PTFE membrane. 
 
 
a. b. c. 
Fig. 4. Failure of a GBR procedure due to premature exposure and infection of an e-PTFE 
membrane three weeks following membrane placement. a. soft tissue dehiscence expose the 
membrane to the oral environment. The membrane is contaminated with dental plaque.  
b. The membrane is surgically removed and the defect debrided c. clinical view of the  
e-PTFE membrane after removal. 
With the development of bioresorbable membranes, and the increasing evidence regarding 
their effectiveness, the use of non-resorbable membranes has become limited to specific 
indications.  
3. Bioresorbable membranes 
Bioresorbable membranes offer many advantages compared with non-resorbable materials. 
Apart from the fact that there is no need for a second surgical intervention for removal of 
the membrane, they present improved soft tissue healing (Lekovic et al. 1997, 1998; 
Zitzmann et al. 1997); the incorporation of the membranes by the host tissues and rapid 
resorbtion if exposed eliminate open microstructures prone to bacterial contamination 
(Zitzmann et al. 1997). Bioresorbable materials that may be used for the fabrication of 
resorbable membranes belong to the groups of natural or synthetic polymers. The best 
known groups of polymers used for medical purposes are aliphatic polyesters and collagen. 
Over the past decade membranes are made of polyglycolide, polylactide or copolymers 
thereof or of collagen (Hutmacher & Hürzeler 1995, Tal et al. 1991, 1996; Tal & Pitaru 1992; 
Moses et al 2005, , Friedmann et al. 2002, von Arx et al. 2001,2005, Rothamel 2005). The 
qualities of a wide variety of bioresorbable membranes have been investigated 
experimentally and clinically (Lundgren et al. 1994; Mayfield et al. 1997; Simion et al. 1997; 
Zitzmann et al. 1997; Buser et al 1999, Tal et al 2008a; Tal et al 2008b). Most researchers and 
clinicians agree that in comparison to non-resorbable membranes, sites treated with 
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bioresorbable membranes present a lower rate of complications, and have thus largely 
replaced the non-resorbable e-PTFE membranes becoming the standard for most clinical 
situations. In a few well designed studies which compared bioresorbable and non-
resorbable membranes, (Zitzmann et al. 1997, 2001; Christensen et al. 2003) no significant 
difference was found between the two treatment modalities. It should be noted however, 
that Chiapasco et al. (2006), who carried out a systematic review of comparitive studies 
between bioresorbable and non-resorbable membranes, concluded that drawing definite 
conclusions was impossible due to a lack of sufficient well designed studies.  
The development of bioabsorbable membranes for GTR started in the late 80's, soon after the 
concept had been considered accepted dental medicine; in the early 90's however, with the 
emerging usage of endosseous implants and the growing need for implants site 
development, regenerative barriers, especially bioabsorbable membranes, received more 
attention. Therapeutic success, complications and failures were reported, most of which 
dealing with inflamatory reactions in the tissues adjacent to some bioresorbable membranes, 
(Sandberg et al. 1993; Piatelli et al. 1995;Aaboe et al. 1998; Kohal et al. 1999; Schliephake and 
Krachtl. 1997).  
4. Developing collagen membranes 
Among the different materials which were experimented and clinically examined for their 
potential application as regenerative tissue barriers, collagen appeared to be an optimal 
choice and was considered to meet most requirements expected from bioabsorbable 
membranes. Collagens are a family of proteins with a well determined triple helical 
configuration. Among these proteins, collagen Type I is most prevalent, constituting 
approximately 25% of the body's proteins and about 80% of the connective tissue proteins. 
Collagen Type I polymerizes to form aggregates of fibers and bundles. Collagens are 
continuously remodeled in the body by degradation and synthesis. Type I collagen is 
degraded only by a specific enzyme - collagenase, and is resistant to any non-specific 
proteolytic degradation. Collagen biocompatibility, biodegradability and low 
immunogenicity render it advantageous for extensive application in pharmaceutical or 
biotechnological disciplines. 
Collagen is a weak antigen and most of its antigenicity resides in the tellopeptides non-
helical terminals of the molecule. These terminals may be removed by enzymes such as 
pepsin, producing atellocolagen. Atellocolagen's weak antigenicity and weak 
immunogenicity (Cooperman and Michaeli 1984; Schlegel et al 1997). As well as its relative 
resistance to degradation, make collagen an optimal choice for implantable devices. 
Additional advantages that it possess are hemostasis, chemotaxix of periodontal ligament 
and gingival fibroblasts (Postlethwaite et al 1978, Yaffe et al 1984, Locci et al 1997), easy 
manipulation and ability to augment tissue thickness (Tal et al 1996). To the best of the 
author's knowledge, cross-linked medical collagen was first introduced for the purpose of 
guided tissue barriers in 1984 (Chu 1985, 1987). Using type I and type III dermal bovine 
collagen, cross linked with Glutaraldehyde (Collagen Inc. Palo Alto, CA) Becker and Tal 
(1984 – unpublished) have successfully examined the application of collagen membranes on 
class II furcation lesions in the lower mandibular molar (Fig. 5). It is noteworthy however 
that extreme care should be taken to avoid any remnants of amids or aldehydes in the final 
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products since if left behind, these may induce a severe inflammation and damage to the 
peripheral tissues (Fig.6). Further laboratory improvements, turned this gluteraldehyde 
cross-linked collagen membranes into a safe and effective device (Pfeifer et al 1989; van Swol 
et al 1993). The main limitation of this membrane (Periogen, Collagen Inc. Palo Alto, CA) 
was a relative rapid absorbtion time varying from 4 – 8 weeks.  
 
 
a. b. c. d. 
Fig. 5. Clinical presentation of a class II Furcation lesion in a lower first molar tooth treated 
with gluteraldehyde cross-linked type I bovine collagen membrane. a. furcal defect is 
carefully debrided b. membrane is placed to seal the class II lesion c. clinical view 1 year 
after surgery d. one year re-entry presents impressive regeneration of the lesion. (Becker and 
Tal, 1984; unpublished).  
  
Fig. 6. Severe inflammatory gingival reaction in a patient in whom a prototype 
glutaraldehyde cross-linked bovine collagen membrane was placed beneath the buccal 
gingiva of the upper front segment, in an attempt to treat gingival recession. The clinical 
assumption was that gluteraldehyde remnants left after the cross-linking process were the 
cause for this severe tissue reaction.  
4.1 Ribose induced cross linking of medical collagen 
Since the resistance of collagen fibrils towards degradation directly relates to the density of 
the intermolecular cross-links, various collagen cross-linking methods have been used 
including aldehyde fixatives and imides and treatments such as hydration and radiations. 
The main drawbacks of such treatments were toxicity and inability to accurately control the 
degree of cross-linking. In 1988 Tanaka et al. described a novel technique to cross-link 
collagen that is safe and clinically effective. Briefly, their invention was based on the fact 
that a glycated collagen-based matrix may be prepared by non-enzymatic glycosylation of 
native collagen fibrils to irreversibly cross-link collagen polypeptide chains. The sugars 
employed as cross-linking agents, especially D-ribose, are typically non-toxic and non-
immunogenic. Since the degree of cross-linking correlates well with mechanical and 
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as desired by monitoring the degree of cross-linking during the procedure (Fig. 7). It has 
been suggested that ribose sugar, practically allows an unlimited degree of cross-linking 
providing a collagen barrier which is extremely resistant to enzymatic degradation. 
Clinically, cross-linked collagen membranes retain integrity for longer periods of time (Paul 
et al. 1992). 
 
Fig. 7. Synthetic production of Enzymatic cross-linked medical collagen (modified from 
Colbar Life Science LTD. Ramat Hasharon, Israel. 
4.2 Bilayered collagen membrane with an internal polylactide layer 
Experimental investigations showed that degradation of collagen membranes may start 
within 4 days to 4 weeks after membrane placement (Zhao et al. 2000; Owens & Yukna 
2001). It was therefore questionable whether rapidly degraded membranes can 
successfully serve as tissue barriers for GBR. In search for different techniques to delay 
membrane degradation, von Arx et al (2002) hypothesized that combining a bilayer 
collagen membrane with an internal polylactide layer may prolong its barrier function, as 
well as enhance the mechanical properties of this hybrid membrane. They evaluated a 
prototype biodegradable bioresorbable collagen-polylactide hybrid membrane and 
compared it to ePTFE membrane placed at similar sites in the canine. Histological and 
histomorphometrical analysis of 2 months specimens, and percentage calculations for 
areas showing bone regeneration showed that ePTFE sites healed significantly better than 
the experimental membrane sites with 53% - 96.9% bone regeneration compared to 57% – 
85% respectively. The experimental membrane induced moderate infiltration of 
lymphocytes and plasma cells adjacent to empty spaces corresponding to polylactide 
fragments. In addition, these reactions appeared to provoke subsequent resorption of 
newly formed bone. No such findings were seen in ePTFE sites. The authors concluded 
that the prototype membrane could not be recommended for clinical use.  
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4.3 Chemical cross-linked porcine type I and III collagens 
In an ongoing search for an improved collagen membrane which combines optimal 
biodegradation over time, high vascularization, favorable tissue integration, and low foreign 
body reaction, Rothamel et al (2005) compared the biodegradation of differently cross-linked 
collagen membranes in rats applying the above mentioned parameters. Five commercially 
available and three experimental membranes (VN) were included: (1) BioGide (BG) (non-
cross-linked porcine type I and III collagens), (2) BioMend (BM), (3) BioMendExtend (BME) 
(glutaraldehyde cross-linked bovine type I collagen), (4) Ossix (OS) (enzymatic-cross-linked 
bovine type I collagen), (5) TutoDent (TD) (non-cross-linked bovine type I collagen, and (6-
8) VN(1-3) (chemical cross-linked porcine type I and III collagens). Specimens were 
randomly allocated in unconnected subcutaneous pouches on the back of Wistar rats. 
Histological examination and histometrical evaluation of explanted specimens representing 
2, 4, 8, 16, and 24 weeks showed that the highest vascularization and tissue integration was 
noted for BG followed by BM, BME, VN and TD, while OS exhibited none. Subsequently, 
biodegradation of BG, BM, BME and VN was faster than TD. Ossix showed only a minute 
amount of superficial biodegradation 24 weeks following implantation. Biodegradation of 
TD, BM, BME, and VN was associated with the presence of inflammatory cells. Within the 
limits of this study, it was concluded that cross-linking of bovine and porcine-derived 
collagen types I and III was associated with prolonged biodegradation, decreased tissue 
integration and vascularization, and in case of TD, BM, BME and VN foreign body reactions 
(Fig 8). 
Tissue Integration,  Vascularization









~ 2 - 4   weeks
~ 4 - 8 weeks
~ 8 - 16 weeks
~ 8 - 16 weeks
> 24 weeks
 
Fig. 8. Prolonged biodegradation seems to be associated with tissue integration, 
vascularization, foreign body reactios and frequency of tissue dehiscence. Partially modified 
from Rothamel et.al.(2005).  
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5. Collagen barrier membranes exposed to the oral environment by 
spontaneous mucosal dehiscence 
Most commercially available collagen barriers have extensively been investigated in both 
animal models, (Pfeifer et al. 1989; Tal et al. 1991, 1996; Hyder et al. 1992; Tal & Pitaru 1992; 
Crigger et al. 1996) and human studies (Van Swol et al 1993; Al Arrayed et al. 1995; 
Zitzmann et al. 1997; Tal 1998, 2004) presenting comparable clinical results to non-
resorbable membranes (Cortellini et al. 1996; Caffesse et al. 1997). It is generally agreed 
that collagen membranes show a lower incidence of spontaneous exposure to the oral 
environment compared with non-resorbable membranes, and unlike non-resorable 
membranes, soft tissue healing following exposure of collagen membranes involves no 
infection (Friedmann et al. 2002; Moses et al. 2005). In a comparative study between 
prematurely exposed non-resorbable membranes (ePTFE), non-cross-linked collagen 
membranes (BioGide) and cross-linked collagen membranes (Ossix), the latter were 
claimed to be superior, and capable of supporting healing (Moses et al. 2005). This finding 
was partially explained by the authors’ impression that in prematurely exposed cases, the 
cross-linked collagen membranes has the capacity to withstand bacterial collagenolytic 
degradation while facilitating soft tissue healing over the exposed membranes (Moses et 
al. 2005). In an attempt to better understand collagen barrier bio-durability and integrity 
in sites treated with cross-linked and non-cross-linked collagen barrier membranes, Tal et 
al (2008a) have clinically and histologically investigated GBR treated sites showing 
spontaneous mucosal perforations over barrier membranes in humans. In 52 patients, 
bony defects were grafted with xenograft and covered with collagen resorbable barrier 
membranes: 26 with cross-linked collagen membranes (Ossix) and 26 with non-cross-
linked collagen membranes (BioGide) (Fig.9). Post-surgical spontaneous mucosal 
perforations and membrane exposures were recorded. Surgical sites were monitored for 6 
months before implant placement.  
During implant placement procedure, full thickness soft tissue discs, 3 mm in diameter, 
were punched out from 18 Ossix and 18 BioGuide sites for histologic examination. Of the 
52 sites, 33 were intact and 19 (36.5%) were associated with spontaneous membrane 
exposure: 13 (50%) were in Ossix sites and 6 (23.1%) in BioGuide sites (p< 0.05). 
Perforation sites clinically healed within 2-4 weeks over both CL and NCL membranes. 
Histologically, Ossix membranes were intact in all 9 non-perforated sites, but in the 
perforated Ossix sites, membranes were interrupted in 5 and undetected in four. 
BioGuide membranes were undetected in all 18 specimens examined. In 3 non-perforated 
Ossix membrane sites, ossification was associated with or within the membrane. It was 
concluded that Ossix membranes were more resistant to tissue degradation than BioGide. 
At non-perforated sites, Ossix membranes maintained integrity during the 6 months study 
period of time while BioGide membranes disintegrated (Fig.10).  
Neither CLM (Ossix) nor NCLM (BioGide) were resistant to degradation when exposed 
to the oral environment. Ossix membranes were associated with a significantly higher 
incidence of tissue perforations compared with BioGidee membranes (Fig. 11).  
There is no satisfactory explanation for the increased incidence of spontaneous exposure 
incidence at CLM treated sites compared with NCLM sites. Based on the observation that  
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Fig. 9. Clinical view of a ridge preservation procedure a. severe bone loss and complete 
resorbtion of the buccal plate of the alveolus associated with a longitudinal root fracture. b. 
the fresh extraction socket is debrided and measured c. the socket and bony defect are 
grafted with xenograft d. the grafted socket and defect are covered with a cross-linked 
collagen resorbable membrane. 
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the degree of cross-linking is negatively correlated with the attachment and proliferation of 
PDL fibroblasts and human osteoblast-like cells observed in in-vitro cultures (Rothamel et al. 
2004), the tendency of the CLM to split from the adjacent connective tissue may be due to lack 
of attachment between the two, and lack of membrane vascularization in the early healing 
phase. This phenomenon has been described by Rothamel et al. (2005) who examined the 
biodegadation of differently cross-linked collagen membranes in the rat and found that the 
Ossix membrane exhibited only slight superficial vascularization and minimal surface 
resorption after 24 weeks compared with Bio-Gide - a native dermal porcine collagen which 
showed early vascularization and over 80% resorption after 8 weeks. It should be stressed that 
in their animal study Rothamel et al (2005) made complete tissue closure in extra-oral 
subcutaneous pouches, while in our human study (Tal et. al. 2008a) a significant number of 
sites were spontaneously exposed to the oral environment. However, bone growth patterns 
shown in this study, included membrane ossification beneath the membrane leaflets and new 
bone growth adherent to the membrane (Figs. 12,13), suggesting high bio-compatibility 
between the membrane and osteoblasts ( Rothamel et al. 2004). Although this study was 
limited to evaluation of membrane bio-durability rather than sub-membraneous bone 
regeneration, it is noteworthy that a recent histological evaluation of changes during 
ossification and cellular events at GBR sites, has shown that in the rat maxillae, NCLM 
(BioGide®) associated with defect-derived bone had integrated to such a degree that it was 
difficult to distinguish the membrane-derived new bone from that generated in the cavity 
(Taguchi et al. 2005). Based on these observations, these authors suggested that NCLM 




Fig. 10. Histological examination of non perforated sites 6 months after membranes 
placement. a. the native collgen membrane (BioGide) completely disintegrated, and its 
location can be identified by the abrupt transition from mature supramambraneous 
connective tissue to young cellular submembraneous connective tissue b. the cross-linked 
membrane (Ossix) maintained integrity and separates between the mature 
supramambraneous connective tissue and the newly established submembraneous 
connective tissue. 
The findings described by Tal et al (2008a,b) are in agreement with the report of von Arx et 
al. (2005) who claimed that in the rabbit calvarium cross-linked collagen membranes clearly 
displayed prolonged membrane integrity compared with non-crossed-linked collagen 
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a. b. 
Fig. 11. a. Histological aspect of CLM remnants in a perforated site. The membrane (CLM) is 
interrupted under the perforation and identified at the peripheral borders of the specimen 
(H&E, original magnification x20). b. Higher magnification (x40) from a. showing 




Fig. 12. Histologic view of CLM remnants in a non-perforated site showing a. new bone 
adhered to the membrane, (H&E, original magnification x20). b. Occasionally bone growth 
is observed between the membrane leaflets penetrating the membrane (CLM) and perhaps 
replacing it (H&E, original magnification x40). 
membrane. However, since their experiment was performed in a close wound, no tissue 
inflammatory response was involved. The studies of Tal et al (2008a,b) disagree with the 
interpretation that in prematurely exposed cases crossed-linked collagen membranes have 
“the capacity to withstand bacterial collagenolytic degradation” when exposed by soft tissue 
dehiscence (Moses et al. 2005). It is noteworthy that long epithelial ridges were observed in 
several of the healed perforation lesions associated with the crossed-linked group (FIG 14). 
Similar epithelial ridges have been previously described by Tal and Dayan ( 2000) and Tal et 
al.( 2001) in human specimens retrieved from mucosal early perforations over submerged 
implants. While no scientific proof is available, it may be logical to assume that these 
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epithelial ridges are remnants of epithelial down-growth that separates the exposed 
membrane from the perforated gingival connective tissue during early healing and before 




Fig. 13. Histologic view of new bone adhered to an ossified CLM in a non-perforated GBR 
site; new bone in intimate contact with graft particles and the resorbed membrane is 




Fig. 14. Histological aspect of a CLM specimen from a perforated site. Long epithelial ridge 
(LER) is shown at the periphery of the healed perforation. b. Long epithelial ridge (LER) is 
shown along the cross-linked membrane remnants (CLM), peripheral to the perforation site. 
A thin layer of connective tissue separates it from the membrane (H&E, original 
magnification x20).  
To further understand the bio-degradation of cross-linked and non-cross-linked collagen 
membranes, an animal study was undertaken in which membranes were experimentally 
exposed to the oral environment (Tal et al 2008b). In 8 cats, 48 surgical procedures were 
performed, 3 along each side of the palate: 32 soft tissue perforations were made, and 16 full 
thickness mini-flaps were raised. Cross-linked and non-cross-linked collagen membranes 
discs were placed either under the perforations and peripheral mucosa and left exposed 
(experimental), or covered by the flaps (controls) (FIG.15).  
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Fig. 15. Clinical view of two experimental perforation sites (top/middle) and one control site 
(bottom) in the cat palate. Top - Cross-linked collagen membrane disc placed under the 
surgically perforated mucosa; Middle – non cross-linked membrane disk placed under the 
surgically perforated mucosa; Bottom - membrane disk placed under surgically elevated 
mucosal flap and then covered (control). 
The four treatment modalities were equally distributed among 8 animals. Study design 
provided 7 and 28 days histological specimens for each treatment modality. Histological 
observations revealed that cross-linked and non-cross-linked collagen membranes remained 
intact in the control sites during the 28 days study period. At 7 and 28 days, Cross-linked 
membranes appeared interrupted in 3 and 2 experimental sites, respectively, and were 
undetected in the remaining experimental sites. There was no statistical difference between 
control specimens and between CLM and NCLM of the different treatment modalities (Fig. 
16). It was concluded that if covered, both cross-linked and non-cross-linked membranes 
were resistant to tissue degradation and maintained continuity throughout the study. 
However, none of the membranes was resistant to degradation when exposed to the oral 
environment, even after 7 days. 
 
 
a. b. c. 
Fig. 16. Histologic view of a. 28-day control NCLM specimen. The NCLM presents intimate 
contact with the palatal bone on the one side and with the soft connective tissue on the other 
side. b. 28-day control CLM specimen. The CLM presents intimate contact with the palatal 
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bone on the one side and with the soft connective tissue on the other side. Connective tissue 
penetration between the membrane and the bone is present and membrane separation to 
leaflets is observed. c. 7-day experimental CLM specimen showing disintegration of the 
membrane under the perforation. Submembraneous granulation tissue growth and 
peripheral epithelial migration are observed. Inflammatory infiltrate is abundant around 
and between the membrane layers. 
6. Increasing the longevity of non cross-linked collagen membranes 
6.1 Double layer native non cross-linked collagen preparation 
In search for formulas that will extend the functional activity of collagen membranes in vivo, 
Kozlovsky et al (2009) have evaluated the bio-degradation of a two layer preparation of a 
native Type I and Type III porcine collagen membrane (Bio-Gide® (BG) (Geistlich, 
Wolhusen, Switzerland)) and compared it with that of the commercially available single 
layer membrane. It has been shown that four weeks after subcutaneous implantation of BG 
membrane in the rat clavaria, reduction in membrane thickness combined with nearly 
complete biodegradation was reported (Zhao et al 2000, Rothamel et al 2005 ). When applied 
in surgical pouches in the palate of mongrel dogs (Owens & Yukna 2001) moderate to 
complete degradation was reported 4-8 weeks following implantation. It has been suggested 
that application of a second layer of Bio-Gide® (BG) membrane (double layer technique) 
may reduce micro movement and improve its stabilization, thus enhancing its protective 
effect in the sub-membranous augmented area (von Arx & Buser 2006). Kozlovsky et al 
(2009) investigated the influence of the additional layer of the barrier membrane on its 
durability by measuring quantitatively the in vivo degradation of barriers composed of one 
vs. two layers of Bio-Gide® The degree of membrane disintegration was histochemically 
measured based on the amount of residual membrane collagen labeled with biotin (Zohar et al. 
2004) . Two circular bony defects, 5-mm in diameter, were made in the calvaria of Wistar rats. 
Bio-Gide® membrane 5-mm diameter discs, labeled with biotin, were placed in these defects 




Fig. 17. Photographs of the surgical procedure. (a) on the mid-line of the parietal bone, (along 
the sagittal suture) two similar, 5-mm diameters, approximately 1 mm deep) bony defects are 
prepared. (b) The labeled membrane discs are laid over one defect as a mono layer membrane 
(MLM) (right) and over the other defect as double layer membrane (DLM) (left)  
Rats were sacrificed after 4 and 9 weeks and histology performed. Membranes were stained 
with Horseradish peroxidase-conjugated Streptavidin and Aminoethyl Carbazole as 
substrate for detection of biotinylated collagen. Collagen degradation in the mono layer BG 
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ranked 60% during 4 weeks post application. The use of two layers of membranes resulted 
in a similar (60%) resorption rate of the initial collagen content however, since the initial 
total collagen content in the double layer membrane was roughly twice the amount of the 
monolayer one, the amount of residual collagen at 4 weeks was significantly greater in the 
double layer sites. The rate of collagen degradation for mono layer and double layer 
membrane sites at 9 weeks was similar (~80%), with twofold amount of residual collagen 
content at the DLM sites. In addition, the residual thickness of the DLM compared with the 
MLM was 81% and 74% after 4 and 9 weeks respectively. Thus, it has been shown that 
despite of similar collagen degradation rates of both MLM and DLM, the application of a 
second layer of Bio-Gide® (BG) membrane (double layer technique) results in a significantly 
greater residual amount of collagen, at least up to 9 weeks post surgery in rats. Since 
membrane thickness was reduced by ~30% between 4 and 9 weeks while the collagen 
surface area was reduced by 50-60% during that period, it may be suggested that the main 
pattern of resorption is an internal rather than an  external one. Since the Bio-Gide® 
membrane is structured like an interconnected porous system with large interstices, it is 
most suitable for transmembranous formation of blood vessels (Schwarz et al 2006), 
facilitating its resorption (Rothamel et al 2004, Schwarz et al 2006). Indeed the 
transmembranous vascularization of the membrane was manifested histologically already 4 
weeks following implantation and become well-defined through all the layers of the 
membrane 9 weeks following implantation (Fig 18).  
  
Fig. 18. Photomicrographs of hematoxylin and eosin-stained mono-layer membrane (MLM), 
9-weekpost-implantation. Original magnification × 100. bv- blood vessel; p- periosteum-like 
structure; b- eosinophilic collagen bundles; w- wavy short fibers; LC- loose connective 
tissue;.  
Schwarz et al (2006) proposed that the vascularization process may also contribute to 
membrane degradation since the monocytes penetrating through the blood vessel wall may 
differentiate into macrophages.Kozlovsky et al (2009) reported that in spite of the difference 
in the thickness of the 2 membrane preparations, similar degradation rate of 80% for both 
membranes was measured at 9 weeks. Since the trans-membranous formation of blood 
vessels is essential for collagen resorption (Schwarz et al 2006), it seems that the 
vascularization of the double layer membrane was not impaired by its increased thickness. 
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It has been claimed that increasing the density of cross links between collagen molecules has 
a negative effect on membrane biocompatibility (Schwarz et al 2006, Rothamel et al 2004), 
membrane to tissue integration and vascularization, and inhibits attachment and 
proliferation of PDL fibroblasts and osteoblasts (Rothamel et al. 2004, 2005). Using a second 
layer of resorbable, cross-linked membrane avoids these disadvantages, while extending 
membrane longevity. In the double layer 9 weeks membrane specimens, central intra – 
membrane neo-ossification was clearly identified with collagen fibers embedded in the 
osteoid (Fig 19), confirming a phenomena previously described by others (Taguchi et al 




Fig. 19. Photomicrographs of a double-layer membrane (DLM) membranes 9-week post-
implantation. a. P-periosteum- like structure; B - eosinophilic collagen bundles; W - wavy 
short fibers; LC - loose connective tissue ;BV-blood vessel; O - osteoblasts. *Newly formed 
bone at the floor of the defect; **central ossification. (Hematoxylin and eosin Original 
magnification × 100). b. Newly formed bone (**) adjacent to the membrane collagen bundles 
(B) with osteoblasts (O) arranged on the surface. Strongly eosinophilic wave-like long 
collagen fibers (W) of the membrane penetrate the osteoblastic layers and incorporate into 
the bone matrix of the centrally neo-ossified membrane. BV, blood vessel; LC, loose 
connective tissue (Hematoxylin and eosin; Original magnification × 200). 
While this finding has never been fully understood, it may be speculated that the significant 
increase in membrane thickness and longevity result in increasing angiogenesis and cellular 
population of the collagen matrix, leading to cell proliferation, differentiation and ossification.  
6.2 Increasing collagen structural stability by collagen membranes immersion and 
systemic tetracycline administration 
In vivo breakdown of medical collagen has thoroughly been investigated. Collagenase, the 
enzyme responsible for collagen biodegradation, belongs to the matrix metalloproteinases 
(MMP’s) family of enzymes which are normally present in Mammalian tissues. Collagenase 
which is produced by a number of body tissues and cells, degrades collagen as part of the 
physiological connective tissue remodeling. Neutrophils, monocytes and fibroblasts are 
believed to play a major role in collagen degradation mechanisms in wounds healing by 
releasing MMPs (Reynolds 1994, Armstrong 2002). In vivo biodegradation of collagen 
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membranes depends on collagenolytic activity; it has, therefore, been suggested that in 
addition to increasing the collagen structural stability by cross-linking, inhibition of MMP’s 
may further slow down the collagen degradation (Golub et al 1998). It has been shown that 
Tetracycline, an antibiotic with anti-collagenolytic properties, inhibits MMPs activity (Golub at 
al 1997, Greenwald at al 1998). It has also been shown that the use of tetracycline-coated 
expanded polytetrafluoroethylene (ePTFE) barrier membranes results in additional gain of 
clinical periodontal attachment, most likely due to its antimicrobial activity (Zarkesh et al. 
1999). Modulation of wound-healing has been successful applying sub dosage formulation of 
TTC, lacking antimicrobial activity while retaining the MMP inhibitory capacity. This 
phenomenon probably occurs due to TTC inhibition of extra-cellular MMP, likely due to its 
chelating activity on Ca++ and Zn++ ions (Golub et al. 1987). Furthermore, inflammatory 
cytokines including TNF-alpha, IL-1 beta, and IL-6 are markedly down-regulated in patients 
during treatment with tetracyclines. This phenomenon also reduces the amount of MMP’s 
present in inflamed tissues, contributing to a reduction of the collagenolytic activity (Chung et 
al 1997). The effect of immersing collagen membranes in varying TTC concentration solutions 
on the in vitro degradation rate was evaluated (Moses et al. 2001) . Membranes were incubated 
in either phosphate buffered saline or with TTC-HCl dissolved in concentrations of 5 mg/ml, 
50 mg/ml or 100 mg/ml. The TTC impregnated and non-impregnated membranes were 
incubated with either bacterial collagenase or cultures of human bone lineage cells. Membrane 
degradation was examined on days 2, 4, 7, and 14. It was concluded that collagen membranes 
immersed in 50 mg/ml TTC solution exhibited the longest degradation time, both in the 
clostridial collagenase and the human bone cell lineage assays. Immersion in a 50 mg/ml TTC 
solution before implantation was, therefore, considered most effective in delaying collagen 
membranes degradation (Moses et al. 2001) [FIG 20].  
 
Fig. 20. Degradation of collagen membrane ( measured as optical density (OD) at the 595 nm 
wave length with (+) and without (-) collagenase in different Tetracycline concentration. 
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These findings suggested the hypothesis that immersion of collagen in TTC prior to 
implantation could delay collagen degradation also in-vivo. The effect of soaking collagen 
membranes in different concentrations of tetracycline hydrochloride solutions (TTC) on 
membranes degradation rate in the rat calvaria (Zohar et al. 2004) was evaluated. Prior to 
implantation in the rat calvaria membranes were labeled with Biotin. The histological slides 
were stained with Avidin and horseradish peroxidase (HRP) to detect remnants of 
biotinylated collagen. Staining intensity was correlated to the amount of the remaining 
collagen and analyzed by image-analysis software. It was found that the staining intensity 
of membranes that were soaked in 50 mg/ml of TTC exhibited > 11-fold higher intensity 
than PBS soaked membranes (control) (Figs. 21-23). It was concluded that soaking collagen 
membranes in 50 mg/ml TTC solution is an effective, practical, and simple tool to reduce 
membrane degradation rate in vivo.  
 
 
a. b. c. 
Fig. 21. Histological view (x40) of the membranes 7 days after implantation with different 
tetracycline (TTC) concentrations. a. Phosphate-buffered saline alone (0 mg/mL TTC);  




a. b. c. 
Fig. 22. Histological view (x40) of the membranes 21 days after implantation with different 
tetracycline (TTC) concentrations. a. Phosphate-buffered saline alone (0 mg/mL TTC);  
b. - 50 mg/mL TTC. c. 100 mg/mL TTC. Collagen stained in red/brown with Avidin-Biotin-
HRP reaction. 
The question of whether administration of subantimicrobial dose of TTC may have an effect 
on the degradation of collagen membranes in vivo still remained. Evaluation of the in vivo 
degradation of collagen membranes treated by combined TTC immersion and systemic 
administration in the rat have showed that immersion of collagen membranes in TTC 
solution prior to their implantation and systemic administration of TTC significantly 
decreased membranes' degradation (Figs. 24, 25). It was therefore concluded that this 
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technique may offer a treatment alternative to reduce bio-degradation and enhance bio-





Fig. 23. Color intensity of biotinylated material as measured by number of colored pixels 





Fig. 24. Histological view (x40) of the membranes 21 days after implantation with different 
tetracycline (TTC) concentrations with systemic administration of TTC. a. Phosphate-
buffered saline alone (0 mg/mL TTC); b. 50 mg/mL TTC. Collagen stained in red/brown 
with Avidin-Biotin-HRP reaction.  
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a. b. 
Fig. 25. Histological view (x40) of the membranes 21 days after implantation with different 
tetracycline (TTC) concentrations without systemic administration of TTC: a. Phosphate-
buffered saline alone (0 mg/mL TTC); 2. 50 mg/mL TTC. b. Collagen stained in red/brown 
with Avidin-Biotin-HRP reaction.  
7. Membrane supporting materials 
Publishd reports have shown that a wide range of membrane supporting materials are suitable 
fulfilling the requirements set, making harvesting of autogenous bone unnecessary for most 
procedures (See Chapters 11-14). It has been shown that in self membrane-supporting defects, 
where there is no need to support the membrane in order to provide space, tissue regeneration 
is superior to that achieved by using membrane supporting agents; in fact, the optimal 
osteoconductive membrane supporting material is one that interferes the least with bone 
regeneration within the membrane occluded space i.e. blood clot (Fig. 26). Among many 
materials, deproteinized bovine bone mineral, a fully synthesized homogenous 
hydroxyapatite and beta tricalcium phosphate, and demineralized and mineralized freezed  
 
 
a. b. c. 
Fig. 26. Experimental guided periodontal regeneration in the dog. a. new bone growth 
(above) in a membrane provided space filled with natural coagulum. New cementum 
(below) and separating periodontal ligament were also regenerated. b. GTR of the same 
space filled with deproteinized Bovine Bone Mineral. Paticles of the xenograft intimately 
surrounded by bone are observed c. higher magnification from b. showing a particle of 
deproteinized Bovine Bone Mineral intimately surrounded by new bone. 
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dried bone allografts, consistently demonstrated satisfactory clinical results. While this 
statement is applicable for for osteoconductive materials, current research is focused on the 
application of growth and differentiation factors - natural proteins and polypeptides  
that regulate tissue regeneration. To learn more about these, the reader is referred to 
chapters 1-5. 
8. Conclusions 
Bioresorbable and non-resorbable membranes can successfully be used for bone 
regeneration. Bioresorbable membranes generally show better clinical performance 
compared with non-resorbable membranes and are the barriers of choice wherever possible. 
The parameters for selecting membranes also include mechanical properties, risk for 
spontaneous early exposure and ease of clinical handling. The search for improved barriers 
is underway; presently, collagen’s biocompatibility, biodegradability and low 
immunogenicity render it advantageous for application in pharmaceutical or 
biotechnological disciplines in general, and in guided bone regeneration in particular. 
Among the membranes examined by our group Ossix* (heavily cross-linked collagen) was 
found to be the most resistant to biodegradeation but showed the least tissue integration 
and vascularization, while BioGide (native, non-cross-linked collagen) presented high tissue 
integration and vascularization. Clinically, Ossix* was associated with a higher rate of soft 
tissue dehiscence followed by rapid resorbtion following membrane exposure to the oral 
environment.  
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